Kotloff, Karen L.
- University of Maryland Baltimore · Pediatrics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,566
- Rising Star
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pediatrics
NIH Funding · FY2023
Linked Award Amount
$3.3M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#1,566
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kotloff, Karen L. as a PI. Multi-PI records show the full award amount for context.
- 5UM1AI148689-04UM1Contact PIImplementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical SiteUniversity of Maryland Baltimore · Pediatrics (NIH department code)$3.3Maward amount
Award organization
Organizations that administered FY2023 awards listing Kotloff, Karen L. as a PI.
FY2023 award administered by University of Maryland Baltimore (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardUniversity of Maryland Baltimore
- 2009$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #7967
- 2010$2M Cumulative Funding
- 2010Entered Top 25% NationallyRanked #1702
- 2010Entered Top 10% NationallyRanked #1702
- 2011$5M Cumulative Funding
- 2011$10M Cumulative Funding
- 2011Entered Top 5% NationallyRanked #455
- 2021$25M Cumulative Funding
- 2021Entered Top 1% NationallyRanked #55
- 2022$50M Cumulative Funding